NU58DP007354
Cooperative Agreement
Overview
Grant Description
Louisiana Actions to Achieve Health Equity to Control Diabetes - Objective: Well-Ahead Louisiana's (WAL) Louisiana Actions to Advance Health Equity to Control Diabetes project proposal will work to decrease risk for type 2 diabetes among adults with prediabetes and improve self-care practices, quality of care, and early detection of complications among people with diabetes. It will also implement evidence-based, family-centered childhood obesity interventions as a type 2 diabetes risk reduction strategy.
Project Proposal: WAL proposes to use statewide and regional strategies to advance health equity for priority populations with or at risk for diabetes in the state of Louisiana. The project will address the social determinants of health (SDOH) that contribute to the disproportionate burden of diabetes in these populations and implement strategies to improve access to care and resources. WAL has demonstrated its ability to reach and serve these populations through previous funding opportunities and will continue to build on that foundation through continued partnerships with community-based organizations, healthcare facilities, and other organizations located in these communities. WAL has chosen priority populations for this work not only based on need, but also considering the strength of its existing partnerships in the region.
Purpose: The purpose of WAL's proposal is to improve the health of Louisiana residents who have disproportionately been burdened with diabetes and pre-diabetes by improving the landscape of diabetes management and prevention.
Outcomes: WAL expects to achieve the following outcomes related to diabetes management and type 2 diabetes prevention as a result of this program:
Short Term:
1. Increased number of organizations implementing evidence-based community behavioral change programs;
2. Increased adaptation/tailoring of effective programs for priority populations;
3. Increased number of patients screened and referred to community resources;
4. Increased SDOH screenings in clinical settings.
Intermediate:
1. Increased participation in evidence-based community behavioral change programs;
2. Increased multi-directional communication between clinical and community resources;
3. Improved self-management of chronic diseases;
4. Increased proportion of the population receiving the health care services they need and want.
Long Term:
1. Decreased proportion of people with diabetes with an A1C > 9%;
2. Increased number of program completers served by CDC-recognized National DPP delivery organizations who reduce their risk for type 2 diabetes;
3. Decreased percent of the 95th percentile body mass index (BMI) and percent of median BMI in children, improvement in pediatric quality of life, and decrease in BMI among caregivers.
Evaluation: WAL will allocate 13% of total funding to its internal epidemiology and evaluation team to carry out the evaluation activities associated with this funding. Evaluation and performance measure planning will be done in a collaborative manner with program staff and partners. Internally, evaluation findings will inform WAL's overall strategy and practices around diabetes prevention and management. Externally, WAL will disseminate evaluation findings to stakeholders through informal check-in meetings, presentations and/or briefs, through the WAL public website, www.wellaheadla.com, in addition to the evaluation reporting requirements to the CDC.
Key Personnel: Key personnel from WAL include Division Manager for Tobacco Control and Disease Prevention, Diabetes Program Manager, Chronic Disease Epidemiologist, Chronic Disease Evaluator, Healthcare Innovation Manager, Diabetes Coordinator, Communications Assistant, Budget Manager, and Administrative Program Specialist.
Project Proposal: WAL proposes to use statewide and regional strategies to advance health equity for priority populations with or at risk for diabetes in the state of Louisiana. The project will address the social determinants of health (SDOH) that contribute to the disproportionate burden of diabetes in these populations and implement strategies to improve access to care and resources. WAL has demonstrated its ability to reach and serve these populations through previous funding opportunities and will continue to build on that foundation through continued partnerships with community-based organizations, healthcare facilities, and other organizations located in these communities. WAL has chosen priority populations for this work not only based on need, but also considering the strength of its existing partnerships in the region.
Purpose: The purpose of WAL's proposal is to improve the health of Louisiana residents who have disproportionately been burdened with diabetes and pre-diabetes by improving the landscape of diabetes management and prevention.
Outcomes: WAL expects to achieve the following outcomes related to diabetes management and type 2 diabetes prevention as a result of this program:
Short Term:
1. Increased number of organizations implementing evidence-based community behavioral change programs;
2. Increased adaptation/tailoring of effective programs for priority populations;
3. Increased number of patients screened and referred to community resources;
4. Increased SDOH screenings in clinical settings.
Intermediate:
1. Increased participation in evidence-based community behavioral change programs;
2. Increased multi-directional communication between clinical and community resources;
3. Improved self-management of chronic diseases;
4. Increased proportion of the population receiving the health care services they need and want.
Long Term:
1. Decreased proportion of people with diabetes with an A1C > 9%;
2. Increased number of program completers served by CDC-recognized National DPP delivery organizations who reduce their risk for type 2 diabetes;
3. Decreased percent of the 95th percentile body mass index (BMI) and percent of median BMI in children, improvement in pediatric quality of life, and decrease in BMI among caregivers.
Evaluation: WAL will allocate 13% of total funding to its internal epidemiology and evaluation team to carry out the evaluation activities associated with this funding. Evaluation and performance measure planning will be done in a collaborative manner with program staff and partners. Internally, evaluation findings will inform WAL's overall strategy and practices around diabetes prevention and management. Externally, WAL will disseminate evaluation findings to stakeholders through informal check-in meetings, presentations and/or briefs, through the WAL public website, www.wellaheadla.com, in addition to the evaluation reporting requirements to the CDC.
Key Personnel: Key personnel from WAL include Division Manager for Tobacco Control and Disease Prevention, Diabetes Program Manager, Chronic Disease Epidemiologist, Chronic Disease Evaluator, Healthcare Innovation Manager, Diabetes Coordinator, Communications Assistant, Budget Manager, and Administrative Program Specialist.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Louisiana
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 200% from $1,100,000 to $3,300,000.
Louisiana Department Of Health was awarded
Louisiana Health Equity Grant: Diabetes Prevention & Management
Cooperative Agreement NU58DP007354
worth $3,300,000
from National Center for Chronic Disease Prevention and Health Promotion in June 2023 with work to be completed primarily in Louisiana United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.988 Cooperative Agreements for State-Based Diabetes Control Programs and Evaluation of Surveillance Systems.
The Cooperative Agreement was awarded through grant opportunity A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes.
Status
(Ongoing)
Last Modified 7/3/25
Period of Performance
6/30/23
Start Date
6/29/28
End Date
Funding Split
$3.3M
Federal Obligation
$0.0
Non-Federal Obligation
$3.3M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU58DP007354
Additional Detail
Award ID FAIN
NU58DP007354
SAI Number
NU58DP007354-1645904550
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CUC0 CDC NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION
Awardee UEI
L2GPNJZBM283
Awardee CAGE
31DL9
Performance District
LA-90
Senators
Bill Cassidy
John Kennedy
John Kennedy
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Health and Human Services (075-0948) | Health care services | Grants, subsidies, and contributions (41.0) | $1,100,000 | 100% |
Modified: 7/3/25